Clinical Research Directory
Browse clinical research sites, groups, and studies.
Apremilast Pregnancy Exposure Registry
Sponsor: University of California, San Diego
Summary
The purpose of the Apremilast Pregnancy Exposure Registry is to monitor planned and unplanned pregnancies exposed to apremilast and to evaluate the safety of this medication relative to specified pregnancy outcomes, and to evaluate potential effects of prenatal apremilast exposure on infant health status through one year of age.
Official title: Apremilast Pregnancy Exposure Registry OTIS Autoimmune Diseases in Pregnancy Project
Key Details
Gender
FEMALE
Age Range
Any - Any
Study Type
OBSERVATIONAL
Enrollment
233
Start Date
2014-11
Completion Date
2025-07
Last Updated
2025-01-28
Healthy Volunteers
Yes
Conditions
Interventions
apremilast
Comparison of women exposed during pregnancy versus women who are not exposed to apremilast
Locations (1)
University of California, San Diego
La Jolla, California, United States